首頁 > 市場調查報告書 > 通訊

市場調查報告書

商品編碼

1477199

功能服務提供者市場，依服務類型、依階段、依治療領域、依最終用戶、依地理位置

Functional Service Providers Market, By Service Type, By Stage, By Therapeutic Area, By End User, By Geography

出版日期: 2024年04月01日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

功能服務供應商（FSP）市場預計 2024 年價值為 169.4 億美元，預計到 2031 年將達到 298.1 億美元，2024 年至 2031 年年複合成長率（CAGR）為 8.4%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	169.4 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	8.40%	2031 年價值預測：	298.1 億美元

圖 1. 功能服務提供者 (FSP) 市場佔有率 (%)（依地區），2024 年

功能服務提供者 (FSP) 旨在代表組織管理不同的後端和管理功能，使他們能夠專注於核心業務活動。他們處理非核心但關鍵的業務職能，例如財務和會計、人力資源管理、採購和供應鏈管理等。這使得客戶組織能夠有效地擴展其營運成本，而無需投資開發廣泛的內部功能。它們有助於提高營運效率並最佳化成本。市場為企業提供了利用專業知識和技術來改進各種功能流程的機會。

市場動態：

功能服務提供者市場的成長是由於擴大採用外包作為降低營運成本和獲得專業領域專業知識的策略而推動的。許多組織希望與 FSP 合作，根據不斷變化的業務需求靈活擴展其營運。市場對某些職能失去控制的擔憂以及關鍵活動過度依賴外部合作夥伴帶來的風險感到克制。然而，自動化技術的進步和創新商業模式的出現等因素正在該領域創造新的機會。供應商正在利用分析、人工智慧和區塊鏈等技術開發行業和特定功能的解決方案。例如，2022 年 9 月，區塊鏈整合電子臨床平台供應商 Triall 與 Mayo Clinic 研究人員合作，推動臨床試驗設計和資料管理技術。此次合作代表著引導全球轉型為分散式臨床研究的重要一步。

研究的主要特點：

該報告對全球功能服務提供者（FSP）市場進行了深入分析，並提供了預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%），考慮到2023年為基準年。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）介紹了全球功能服務提供者（FSP）市場的主要參與者。
本研究涵蓋的主要公司包括 IQVIA、Parexel International Corporation、ICON plc、PRA Health Sciences、Covance Inc.、Charles River Laboratories International Inc.、Syneos Health、Pharmaceutical Product Development LLC (PPD)、Medpace Holdings Inc.。藥明康德、埃森哲、Cognizant、Quanticate 和BioPoint Inc.
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球功能服務提供者（FSP）市場報告迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球功能服務提供者（FSP）市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東協
亞太其他地區
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
南非
北非
中非

第 9 章：公司簡介 - 全球功能服務供應商 (FSP) 市場

IQVIA
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽
Parexel International Corporation
ICON plc
PRA Health Sciences
Covance Inc.
Charles River Laboratories International Inc.
Syneos Health
Pharmaceutical Product Development LLC (PPD)
Medpace Holdings Inc.
LabCorp
Wuxi AppTec
Accenture
Cognizant
Quanticate
BioPoint Inc.

第 10 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI5962

The functional service providers (FSP) market is estimated to be valued at USD 16.94 Bn in 2024 and is expected to reach USD 29.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 16.94 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	8.40%	2031 Value Projection:	US$ 29.81 Bn

Figure 1.Functional Service Providers (FSP) Market Share (%), By Region, 2024

Functional Service Providers Market - IMG1

Functional service providers (FSPs) aim to manage different back-end and administrative functions on behalf of organizations enabling them to focus on their core business activities. They handle non-core but critical business functions such as finance and accounting, human resource management, procurement, and supply chain management among others. This allows client organizations to scale their operations cost effectively without having to invest in developing extensive in-house functional capabilities. They help improve operational efficiency and optimize costs. The market provides opportunities for enterprises to leverage specialized expertise and technologies for improving various functional processes.

Market Dynamics:

The growth of the functional service providers market growth is driven by the increasing adoption of outsourcing as a strategy for reducing operational costs and gaining access to specialized domain expertise. Many organizations look to work with FSPs to scale their operations flexibly according to changing business needs. The market sees restraints from concerns around loss of control over certain functions and risks related to over-dependence on external partners for critical activities. However, factors such as advancements in automation technologies and emergence of innovative business models are creating new opportunities in this space. Vendors are developing industry and function-specific solutions leveraging technologies like analytics, AI and blockchain. For instance, in September 2022, Triall, a blockchain-integrated eClinical platform provider, collaborated with Mayo Clinic researchers to advance clinical trial design and data management techniques. This collaboration represents an essential step forward in guiding a global transformation toward decentralized clinical research.

Key Features of the Study:

This report provides an in-depth analysis of the global functional service providers (FSP) market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global functional service providers (FSP) market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include IQVIA, Parexel International Corporation, ICON plc, PRA Health Sciences, Covance Inc., Charles River Laboratories International Inc., Syneos Health, Pharmaceutical Product Development LLC (PPD), Medpace Holdings Inc., LabCorp, Wuxi AppTec, Accenture, Cognizant, Quanticate, and BioPoint Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global functional service providers (FSP) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global functional service providers (FSP) market.

Detailed Segmentation:

Service Type:
- Clinical Trail Design and Monitoring
- Regulatory Affairs
- Data Management
- Pharmacovigilance and Drug Safety
- Biostatistics/Programming
- Medical Writing
- Others
Stage:
- Clinical Development
- Post Approval
Therapeutic Area:
- Oncology
- Cardiovascular
- Infectious Diseases
- Central Nervous System (CNS)
- Respiratory
- Immunology
- Gastrointestinal
- Others
End User:
- Biopharmaceutical Companies
- Medical Device Companies
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- IQVIA
- Parexel International Corporation
- ICON plc
- PRA Health Sciences
- Covance Inc.
- Charles River Laboratories International Inc.
- Syneos Health
- Pharmaceutical Product Development LLC (PPD)
- Medpace Holdings Inc.
- LabCorp
- Wuxi AppTec
- Accenture
- Cognizant
- Quanticate
- BioPoint Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Stage
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Like, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Healthcare Spending by Country

4. Global Functional Service Providers (FSP) Market, By Service Type, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Clinical Trial Design and Monitoring, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Regulatory Affairs, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Data Management, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Pharmacovigilance and Drug Safety, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Biostatistics/Programming, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Medical Writing, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Others, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)

5. Global Functional Service Providers (FSP) Market, By Stage, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Clinical Development, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Post Approval, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)

6. Global Functional Service Providers (FSP) Market, By Therapeutic Area, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Oncology, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Cardiovascular, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Infectious Diseases, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Central Nervous System (CNS), 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Respiratory, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Immunology, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Gastrointestinal, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Others, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)

7. Global Functional Service Providers (FSP) Market, By End User, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Biopharmaceutical Companies, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Medical Device Companies, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)
Others, 2019 - 2031 (USD BN)
- Introduction
- Market Size and Forecast, 2019 - 2031, (USD BN)

8. Global Functional Service Providers (FSP) Market, By Region, 2019 - 2031 (USD BN)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (USD BN)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (USD BN)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
China
India
Japan
Australia
South Korea
ASEAN
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
Brazil
Mexico
Argentina
Rest Of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Stage, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD BN)
- Market Size and Forecast, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, By Country, 2019 - 2031, (USD BN)
South Africa
North Africa
Central Africa

9. Company Profiles - Global Functional Service Providers (FSP) Market

IQVIA
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Parexel International Corporation
ICON plc
PRA Health Sciences
Covance Inc.
Charles River Laboratories International Inc.
Syneos Health
Pharmaceutical Product Development LLC (PPD)
Medpace Holdings Inc.
LabCorp
Wuxi AppTec
Accenture
Cognizant
Quanticate
BioPoint Inc.